RT info:eu-repo/semantics/article
T1 Macroloides for the treatment of severe respiratory illness caused by novel H1N1 swine influenza viral strains
A1 Bermejo Martín, Jesús Francisco
A1 Kelvin, David J.
A1 Eiros Bouza, José María
A1 Castrodeza Sanz, José Javier
A1 Ortiz de Lejarazu Leonardo, Raúl
K1 Gripe - Vacunas
AB The current outburst of a new H1N1 swine influenza strain(s) in México and the United States is causing great concern in health authorities and in the general population [1]. With the World Health Organization (WHO) reporting the pandemic potential of the new strain, it is necessary to determine which therapeutic options are available until a specific vaccine is available. Based on information from the Centre for Disease Control (CDC), the virus is sensitive to oseltamivir and zanamivir. Antivirals are strongly affected by viral mutations; thus their efficiency could be lost as the virus changes.
SN 1972-2680
YR 2009
FD 2009
LK http://uvadoc.uva.es/handle/10324/13854
UL http://uvadoc.uva.es/handle/10324/13854
LA eng
NO Journal of Infection  Developing Countries 2009; 3(3):159-161.
NO Producción Científica
DS UVaDOC
RD 26-abr-2024